A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Drug Conjugate) given intravenously in patients with advanced solid tumours.-Reference-Cited by-同舟云学术

A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Drug Conjugate) given intravenously in patients with advanced solid tumours.

Published:2018-05-20 Issue:15_suppl Volume:36 Page:TPS2610-TPS2610
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Banerji Udai¹,Cook Natalie²,Evans T.R. Jeffry³,Moreno Candilejo Irene⁴,Roxburgh Patricia⁵,Kelly Claire L. S.⁶,Sabaratnam Narmatha⁴,Passi Rashmi⁴,Leslie Sawretse⁷,Katugampola Sidath⁷,Godfrey Lisa⁷,Tremayne Neil⁷,Bennett Gavin⁸,Koehler Maria⁸,Langford Gillian⁸,Symeonides Stefan N.⁹,Pittman Marc⁷

Affiliation:

1. The Institute of Cancer Research and The Royal Marsden, London, United Kingdom;

2. University of Manchester, Manchester, United Kingdom;

3. Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom;

4. The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;

5. Beaston Inst for Cancer Center, Glasgow, United Kingdom;

6. The Christie NHS Foundation Trust, Manchester, United Kingdom;

7. Cancer Research UK Centre for Drug Development, London, United Kingdom;

8. Bicycle Therapeutics Ltd, Cambridge, United Kingdom;

9. University of Edinburgh & Cancer Research UK Centre for Drug Development, Edinburgh, United Kingdom;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2018.36.15_suppl.TPS2610

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro and in vivo evaluation of Bombesin-MMAE conjugates for targeted tumour therapy;European Journal of Medicinal Chemistry;2024-11

2. Nature-inspired and medicinally relevant short peptides;Exploration of Drug Science;2023-06-27

3. Current development of bicyclic peptides;Chinese Chemical Letters;2023-06

4. Serum of Mice Immunized with MT1-MMP Metalloproteinase Reduces Migration Potential of Pancreatic Cancer Cells;Molecular Biology;2021-11

5. Biomedical Relevance of Novel Anticancer Peptides in the Sensitive Treatment of Cancer;Biomolecules;2021-07-29